Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neurol Sci. 2009 Jul 15;282(1-2):12-20. doi: 10.1016/j.jns.2009.01.018. Epub 2009 Feb 26.

Gray matter pathology in (chronic) MS: modern views on an early observation.

Author information

  • 1Dept. of Pathology, VU University Medical Center, Amsterdam, The Netherlands. j.geurts@vumc.nl

Abstract

Involvement of the gray matter (GM) in the pathology of multiple sclerosis (MS) was already recognized in the early days of MS research, but the detection of (cortical) GM lesions under the microscope and with magnetic resonance imaging (MRI) techniques was initially suboptimal and could only recently be enhanced. The visualization of GM lesions in vivo opens new doors for studies focusing on clinical, especially cognitive, effects of GM pathology, as well as for monitoring of neuroprotective treatment. However, so far little is known about what causes GM pathology. In this review, several pathogenetic mechanisms will be discussed, affecting the MS brain both from the 'outside-in' and from the 'inside-out'. Also, the use and reliability of MRI atrophy measures as a monitoring tool for GM damage in the therapeutic setting will be reviewed.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk